A focused pipeline.
MGAM advances one rare-disease program, in classic Pelizaeus-Merzbacher disease, and builds software of its own alongside it.
Life Sciences — Active pipeline
Rare-disease programs centered on defined patient populations, focused development strategies, and substantial unmet need.
| Program | Indication | Candidate | Regulatory milestone |
|---|---|---|---|
| MGAM-003Classic PMD | Classic Pelizaeus-Merzbacher diseaseRare pediatric disease | Clemastine fumarate | Rare Pediatric Disease Designation granted |
Software — In beta
Tools the group writes itself and releases free under its own name, each built to do one job. They are research software, not medical devices, and they neither diagnose nor recommend treatment.
| Product | What it does | Platform | Status |
|---|---|---|---|
| WalkfigureMovement analysis | Gait analysis from one phone videoMeasured on your own computer; nothing is uploaded | Windows | Free — in beta |
Walkfigure is described in full on its own page, with what it measures and what it does not.